Regeneron Pharmaceuticals, Inc. (REGN) Stock Overview
NASDAQ · Healthcare · Biotechnology
About Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases;…
Source: Yahoo Finance
Sector & Industry
Regeneron Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Regeneron Pharmaceuticals, Inc. at a Glance
| Company | Regeneron Pharmaceuticals, Inc. |
| Ticker | REGN |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $676.69 |
| Market cap | $70.94B |
| P/E ratio (trailing) | 16.53 |
| EPS (trailing) | $40.94 |
| 52-week high | $821.11 |
| 52-week low | $541.00 |
| Dividend yield | 56.00% |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 15,343 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →Frequently Asked Questions
What is Regeneron Pharmaceuticals, Inc.'s P/E ratio?
Regeneron Pharmaceuticals, Inc. (REGN) has a trailing P/E ratio of 16.53 as of our latest data snapshot.
What is Regeneron Pharmaceuticals, Inc.'s market cap?
Regeneron Pharmaceuticals, Inc.'s market capitalisation is $70.94B based on the most recent snapshot.
What is REGN's 52-week range?
Over the past 52 weeks, REGN has traded between $541.00 and $821.11.
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Related Healthcare Stocks
Data snapshot: 18 July 2026 (Yahoo Finance) · Page last built: